FDA Approves Unknown Drug — RISING

# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals received FDA approval for an abbreviated new drug application (ANDA 203364) on July 18, 2014, expanding its portfolio of generic medications and positioning the company to capture additional market share in the competitive generic drug sector. The approval strengthens Rising's competitive standing and enables the company to offer healthcare providers and patients a cost-effective therapeutic alternative.